New cast for a new era: preclinical cancer drug development revisited

Area of Science:

• Oncology
• Translational Research
• Drug Development

Background:

• Molecularly targeted agents represent a promising therapeutic strategy for cancer treatment, aiming to reduce patient morbidity and mortality.
• Current preclinical drug evaluations demonstrate limitations in accurately predicting clinical efficacy, highlighting an urgent need for improved methodologies.
• Despite the need for effective anticancer compounds, existing preclinical models often fail to meet the demands of drug development.

Purpose of the Study:

• To review the development of successful preclinical antineoplastic agents.
• To discuss the limitations associated with current preclinical drug evaluation methods.
• To explore alternative strategies for predicting clinical outcomes in cancer research.

Main Methods:

• Review of existing literature on preclinical antineoplastic agents.
• Analysis of limitations in current preclinical cancer models.
• Examination of novel preclinical strategies, including advanced mouse models and co-clinical study designs.

Main Results:

• Successful preclinical antineoplastic agents have been developed, but their translation to clinical success is often hindered by limitations in predictive models.
• Sophisticated mouse models and co-clinical study designs are emerging as key strategies to improve the predictive value of translational cancer research.
• Current preclinical evaluations frequently lack the necessary accuracy to reliably predict the clinical performance of anticancer drugs.

Conclusions:

• Enhancing preclinical strategies is crucial for improving the success rate of molecularly targeted agents in cancer therapy.
• Advanced preclinical models and co-clinical studies hold significant potential to bridge the gap between laboratory findings and clinical outcomes.
• Further development and validation of innovative preclinical methods are essential to accelerate the delivery of effective anticancer therapies to patients.